Last R$88.00 BRL
Change Today +11.00 / 14.29%
Volume 100.0
PFIZ34 On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 2:09 PM 11/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John D. Young

Group President of Global Established Pharma Business, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$5,201,055
As of Fiscal Year 2013

Background*

Mr. John D. Young has been Group President of Value Products Group at Pfizer Inc. since January 1, 2014. Mr. Young served as President and General Manager of Primary Care Business Unit at Pfizer Inc. from June 1, 2012 to December 2013. He served as Regional President of Europe and Canada for The Primary Care Business at Pfizer Inc. from 2009 to June 1, 2012. Over his 25-year career with Pfizer, Mr. Young has held a number of commercial positions with the company, including ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$810,075
Total Annual Compensation$810,075

Stock Options*

Restricted Stock Awards$1,121,732
All Other Compensation$192,312
Exercisable Options124,100
Exercisable Options Value$433,725
Total Value of Options$433,725
Total Number of Options124,100

Total Compensation*

Total Annual Cash Compensation$2,077,387
Total Short Term Compensation$810,075
Other Long Term Compensation$1,314,044
Total Calculated Compensation$5,201,055
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ34:BZ R$88.00 BRL +11.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC - BDR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.